Product Description
Experience the exclusive power of Teicoplanin Injection IP, meticulously formulated in select strengths of 200 mg or 400 mg per vial. This antibacterial is unassailable against serious Gram-positive infections, including MRSA, delivering brilliant efficacy where it matters most. Each vial comes with sterile water for injection, ensuring clear, colorless to pale yellow solutions upon reconstitution. Enjoy peace of mind with the finest manufacturing standards from India-a prescription-only solution that combines advanced safety with discounted access through select suppliers. Store below 25C, protected from light and moisture.
Versatility and Application of Teicoplanin Injection IP
Teicoplanin Injection IP is suitable for all age groups, making it an adaptable solution for both adults and children with Gram-positive bacterial infections. Its surface of application is strictly parenteral, administered via intravenous (IV) or intramuscular (IM) routes. The site of application is the bloodstream, ensuring rapid delivery to systemic infection sites. For optimal results, administration should always be under medical supervision, maximizing both safety and therapeutic effectiveness.
Global Export Markets and Assurance in Supply Chain
Teicoplanin Injection IP is dispatched to main export markets including Asia, Africa, and the Middle East. Each unit undergoes rigorous packing & dispatch procedures, ensuring stability and potency upon arrival. Logistics are managed efficiently to expedite delivery times for sample requests as well as bulk orders. The product is available with necessary certifications, maintaining compliance with international standards for quality and safety. Sample availability further demonstrates commitment to excellence in supply partnerships.
FAQ's of Teicoplanin Injection IP:
Q: How should Teicoplanin Injection IP be administered?
A: Teicoplanin Injection IP is reconstituted with sterile water for injection and administered either intravenously (IV) or intramuscularly (IM). Follow the dosage guidelines provided by the prescribing physician.
Q: What are the main indications for using Teicoplanin Injection IP?
A: This injection is indicated for serious Gram-positive bacterial infections, including MRSA, bone and joint infections, endocarditis, and septicemia.
Q: When should I avoid using Teicoplanin Injection IP?
A: Avoid this medication in cases of known hypersensitivity to teicoplanin or other glycopeptides. If you experience severe allergic reactions or side effects, consult your healthcare provider immediately.
Q: Where is Teicoplanin Injection IP manufactured and exported from?
A: This medicine originates in India and is exported to various international markets, including Asia and Africa, ensuring global access to quality antibacterial treatment.
Q: What process should be followed after reconstituting Teicoplanin Injection IP?
A: After using the provided sterile water to reconstitute the vial, ensure the solution is clear and colorless to pale yellow. Use the dose immediately as directed by your physician.
Q: What precautions need to be considered during prolonged therapy?
A: During extended treatment with Teicoplanin Injection IP, regular monitoring of renal function is recommended to prevent potential nephrotoxicity.